SVEP1 as a genetic modifier of TEK-related primary congenital glaucoma

TL Young, KN Whisenhunt, J Jin… - … & visual science, 2020 - iovs.arvojournals.org
TL Young, KN Whisenhunt, J Jin, SM LaMartina, SM Martin, T Souma, V Limviphuvadh
Investigative ophthalmology & visual science, 2020iovs.arvojournals.org
Purpose: Affecting children by age 3, primary congenital glaucoma (PCG) can cause
debilitating vision loss by the developmental impairment of aqueous drainage resulting in
high intraocular pressure (IOP), globe enlargement, and optic neuropathy. TEK
haploinsufficiency accounts for 5% of PCG in diverse populations, with low penetrance
explained by variable dysgenesis of Schlemm's canal (SC) in mice. We report eight families
with TEK-related PCG, and provide evidence for SVEP1 as a disease modifier in family 8 …
Abstract
Purpose: Affecting children by age 3, primary congenital glaucoma (PCG) can cause debilitating vision loss by the developmental impairment of aqueous drainage resulting in high intraocular pressure (IOP), globe enlargement, and optic neuropathy. TEK haploinsufficiency accounts for 5% of PCG in diverse populations, with low penetrance explained by variable dysgenesis of Schlemm's canal (SC) in mice. We report eight families with TEK-related PCG, and provide evidence for SVEP1 as a disease modifier in family 8 with a higher penetrance and severity.
Methods: Exome sequencing identified coding/splice site variants with an allele frequency less than 0.0001 (gnomAD). TEK variant effects were assayed in construct-transfected HEK293 cells via detection of autophosphorylated (active) TEK protein. An enucleated eye from an affected member of family 8 was examined via histology. SVEP1 expression in developing outflow tissues was detected by immunofluorescent staining of 7-day mouse anterior segments. SVEP1 stimulation of TEK expression in human umbilical vascular endothelial cells (HUVECs) was measured by TaqMan quantitative PCR.
ARVO Journals